One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Identifying Childhood Cancer Survivors at Increased Genetic Risk for Second Malignant Neoplasms: Use of a Novel Screening Tool.
Mostafavi, Roya M. MS 1; Nichols, Kim E. MD 1,,
doi : 10.1200/JCO.21.01817
Volume 39(29) pgs. 3195-3309 October 10, 2021
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer.
Singh, Harshabad MBBS 1,2,3; Perez, Kimberly MD 1,2,3,; Wolpin, Brian M. MD, MPH 1,2,3,; Aguirre, Andrew J. MD, PhD 1,2,3,,
doi : 10.1200/JCO.21.01510
Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Cullinan, Noelle MD 1,2; Schiller, Ian MSc 3; Di Giuseppe, Giancarlo MPH 4,5; Mamun, Mohammed PhD 1; Reichman, Lara MSc 6,; Cacciotti, Chantel MD 7,8; Wheaton, Laura MD 9; Caswell, Kimberly BSc 1; Di Monte, Bruna BScN 4; Gibson, Paul MD 7,; Johnston, Donna L. MD 10; Fleming, Adam MD 7; Pole, Jason D. PhD 5,11; Malkin, David MD 1,; Foulkes, William D. PhD 12,; Dendukuri, Nandini PhD 3; Goudie, Catherine MD 6,13,; Nathan, Paul C. MD 1
doi : 10.1200/JCO.21.00018
FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.
Schmitt-Hoffner, Felix MSc 1,2,3; van Rijn, Sjoerd PhD 1,2; Toprak, Umut H. PhD 1,4; Mauermann, Monika 1,2; Rosemann, Felix MSc 1,2,3; Heit-Mondrzyk, Anke MSc 1,2,3; Hubner, Jens-Martin PhD 1,2,3,; Camgoz, Aylin PhD 1,2,5; Hartlieb, Sabine MSc 1,4,; Pfister, Stefan M. MD 1,2,6,; Henrich, Kai-Oliver PhD 1,4; Westermann, Frank PhD 1,4; Kool, Marcel PhD 1,2,7,
doi : 10.1200/JCO.20.02540
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
Irwin, Meredith S. MD 1,; Naranjo, Arlene PhD 2,; Zhang, Fan F. MSc 3; Cohn, Susan L. MD 4,; London, Wendy B. PhD 5,; Gastier-Foster, Julie M. PhD 6,7,; Ramirez, Nilsa C. MD 6,7; Pfau, Ruthann PhD 6,7; Reshmi, Shalini PhD 6,7; Wagner, Elizabeth MSc 6; Nuchtern, Jed MD 8,; Asgharzadeh, Shahab MD 9; Shimada, Hiroyuki MD, PhD 10; Maris, John M. MD 11,; Bagatell, Rochelle MD 11,; Park, Julie R. MD 12; Hogarty, Michael D. MD 11,
doi : 10.1200/JCO.21.00278
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.
Dahan, Laetitia MD, PhD 1,,; Williet, Nicolas MD 2; Le Malicot, Karine MS 3; Phelip, Jean-Marc MD, PhD 2,; Desrame, Jerome MD 4,; Bouche, Olivier MD, PhD 5,; Petorin, Caroline MD 6; Malka, David MD, PhD 7,; Rebischung, Christine MD 8; Aparicio, Thomas MD, PhD 9,; Lecaille, Cedric MD 10; Rinaldi, Yves MD 11,; Turpin, Anthony MD 12,; Bignon, Anne-Laure MD 13,; Bachet, Jean-Baptiste MD, PhD 14,; Seitz, Jean-Francois MD, PhD 1,; Lepage, Come MD, PhD 15,16,; Francois, Eric MD 17,; for the PRODIGE 35 Investigators/Collaborators
doi : 10.1200/JCO.20.03329
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).
Demeestere, Isabelle MD, PhD 1,,; Racape, Judith PhD 2; Dechene, Julie BSc 3; Dupuis, Jehan MD 4,; Morschhauser, Franck PhD 5,; De Wilde, Virginie PhD 6,; Lazarovici, Julien MD 7,; Ghesquieres, Herve MD 8,; Touati, Mohamed MD 9,; Sibon, David MD 10,; Alexis, Magda MD 11; Gac, Anne-Claire MD 12; Moatti, Hannah MD 13; Virelizier, Emmanuelle MD 14; Maisonneuve, Herve MD 15; Pranger, Delphine MD 16; Houot, Roch PhD 17; Fornecker, Luc-Matthieu PhD 18,; Tempescul, Adrian MD 19; Andre, Marc MD 20,; Casasnovas, Rene-Olivier MD 21,
doi : 10.1200/JCO.21.00068
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Desai, Pinkal M. MD, MPH 1,,; Brown, Janice MD 2,; Gill, Saar MD 3,; Solh, Melham M. MD 4,; Akard, Luke P. MD 5,; Hsu, Jack W. MD 6,; Ustun, Celalettin MD 7,; Andreadis, Charalambos MD 8,; Frankfurt, Olga MD 9,; Foran, James M. MD 10,; Lister, John MD 11,; Schiller, Gary J. MD 12,; Wieduwilt, Matthew J. MD 13,; Pagel, John M. MD 14,; Stiff, Patrick J. MD 15,; Liu, Delong MD 16,; Khan, Irum MD 17,; Stock, Wendy MD 18,; Kambhampati, Suman MD 19; Tallman, Martin S. MD 20,; Morris, Lawrence MD 4; Edwards, John MD 5,; Pusic, Iskra MD 21,; Kantarjian, Hagop M. MD 22,; Mamelok, Richard MD 23,; Wong, Alicia BS 23,; Van Syoc, Rodney BS 23,; Kellerman, Lois BS, MA 23; Panuganti, Swapna PhD 23; Mandalam, Ramkumar PhD 23,; Abboud, Camille N. MD 21,; Ravandi, Farhad MD 22,
doi : 10.1200/JCO.20.01739
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.
Hong, Shaodong MD 1; Zhang, Yaxiong MD 1; Yu, Gengsheng MD 2; Peng, Peijian MD 3; Peng, Jiewen MD 4; Jia, Jun MD 5; Wu, Xuan MD 6; Huang, Yan MD 1; Yang, Yunpeng MD 1; Lin, Qing MD 7; Xi, Xuping MD 8; Xu, Mingjun MD 9; Chen, Dongping MD 10; Lu, Xiaojun MD 11; Wang, Rensheng MD 12; Cao, Xiaolong MD 13; Chen, Xiaozhong MD 14; Lin, Zhixiong MD 15; Xiong, Jianping MD 16; Lin, Qin MD 17; Xie, Conghua MD 18; Li, Zhihua MD 19; Pan, Jianji MD 20; Li, Jingao MD 21; Wu, Shixiu MD 22; Lian, Yingni MD 23; Yang, Quanlie MD 24; Zhao, Chong MD 25; Fang, Wenfeng MD, PhD 1; Zhang, Li MD 1,
doi : 10.1200/JCO.21.00396
Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.
Salerno, Elizabeth A. PhD, MPH 1,2,; Culakova, Eva PhD 3; Kleckner, Amber S. PhD 3,4; Heckler, Charles E. PhD 3,4; Lin, Po-Ju PhD, MPH 3,4; Matthews, Charles E. PhD 2; Conlin, Alison MD, MPH 5,; Weiselberg, Lora MD 6; Mitchell, Jerry MD 7,; Mustian, Karen M. PhD, MPH 3,4; Janelsins, Michelle C. PhD, MPH 3,4,
doi : 10.1200/JCO.20.03514
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis.
Lambertini, Matteo MD, PhD 1,2,,; Blondeaux, Eva MD 1,3; Bruzzone, Marco MSc 4; Perachino, Marta MD 1,2; Anderson, Richard A. MD 5,; de Azambuja, Evandro MD, PhD 6,; Poorvu, Philip D. MD 7,; Kim, Hee Jeong MD 8; Villarreal-Garza, Cynthia MD, PhD 9,10,; Pistilli, Barbara MD 11,; Vaz-Luis, Ines MD, PhD 11,; Saura, Cristina MD, PhD 12,; Ruddy, Kathryn J. MD, MPH 13,; Franzoi, Maria Alice MD 11; Sertoli, Chiara MD 1; Ceppi, Marcello MSc 4; Azim, Hatem A. Jr MD, PhD 9,; Amant, Frederic MD, PhD 14,15,; Demeestere, Isabelle MD, PhD 16,; Del Mastro, Lucia MD 1,3,; Partridge, Ann H. MD, MPH 7,; Pagani, Olivia MD 17,; Peccatori, Fedro A. MD, PhD 18,
doi : 10.1200/JCO.21.00535
ROCKing Chronic Graft-Versus-Host Disease.
Heine, Annkristin MD; Holderried, Tobias A. W. MD; Wolf, Dominik MD
doi : 10.1200/JCO.21.01081
Reply to A. Heine et al.
Lazaryan, Aleksandr MD, MPH, PhD; Lee, Stephanie J. MD, MPH
doi : 10.1200/JCO.21.01559
